Eléments de l'association
|  |
List of bibliographic references
Number of relevant bibliographic references: 22.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000601 | Philip Seeman [Canada] | Parkinson's disease treatment may cause impulse-control disorder via dopamine D3 receptors. |
| 001062 | Philip Seeman [Canada] ; Michele Tinazzi [Italie] | Loss of dopamine neuron terminals in antipsychotic-treated schizophrenia; relation to tardive dyskinesia |
| 001459 | Terence K. Y. Lai [Canada] ; Philip Seeman [Canada] ; Fang Liu [Canada] | Cell membrane lytic action of metoclopramide and its relation to tardive dyskinesia |
| 001889 | Sheng Chen [Canada] ; Philip Seeman [Canada] ; Fang Liu [Canada] | Antipsychotic drug binding in the substantia nigra: An examination of high metoclopramide binding in the brains of normal, Alzheimer's disease, Huntington's disease, and Multiple Sclerosis patients, and its relation to tardive dyskinesia |
| 002002 | Philip Seeman [Canada] ; Hong-Chang Guan [Canada] | Glutamate agonists for treating schizophrenia have affinity for dopamine D2High and D3 receptors |
| 002003 | Philip Seeman [Canada] ; Hong-Chang Guan [Canada] | Glutamate agonist LY404,039 for treating schizophrenia has affinity for the dopamine D2High receptor |
| 002305 | Philip Seeman [Canada] ; Carla Caruso [Argentine] ; Mercedes Lasaga [Argentine] | Memantine agonist action at dopamine D2High receptors |
| 002333 | Philip Seeman [Canada] | Dopamine D2High receptors moderately elevated by bifeprunox and aripiprazole |
| 002576 | Philip Seeman [Canada] ; Patrick N. Mccormick [Canada] ; Shitij Kapur [Canada] | Increased dopamine D2High receptors in amphetamine‐sensitized rats, measured by the agonist [3H](+)PHNO |
| 002612 | Philip Seeman [Canada] | Antiparkinson therapeutic potencies correlate with their affinities at dopamine D2High receptors |
| 002804 | Philip Seeman [Canada] ; Johannes Schwarz [Allemagne] ; Jiang-Fan Chen [États-Unis] ; Henry Szechtman [Canada] ; Melissa Perreault [Canada] ; G. Stanley Mcknight [États-Unis] ; John C. Roder [Canada] ; Rémi Quirion [Canada] ; Patricia Boksa [Canada] ; Lalit K. Srivastava [Canada] ; Kazuhiko Yanai [Japon] ; David Weinshenker [États-Unis] ; Tomiki Sumiyoshi [Japon] | Psychosis pathways converge via D2High dopamine receptors |
| 002F82 | Philip Seeman [Canada] | Atypical antipsychotics: mechanism of action. |
| 003071 | Philip Seeman [Canada] ; Bertha Madras [États-Unis] | Methylphenidate elevates resting dopamine which lowers the impulse-triggered release of dopamine: a hypothesis |
| 003C09 | Philip Seeman [Canada] ; D. Roy Corbett [États-Unis] ; Hubert H. M. Van Tol [Canada] | Atypical neuroleptics have low affinity for dopamine D2 receptors or are selective for D4 receptors |
| 004392 | Philip Seeman [Canada] ; Hong-Chang Guan [Canada] ; Hubert H. M. Van Tol [Canada] ; Hyman B. Niznik [Canada] | Low density of dopamine D4 receptors in Parkinson's, schizophrenia, and control brain striata |
| 004415 | Philip Seeman [Canada] ; Carla Ulpian [Canada] ; Robert D. Larsen [États-Unis] ; Paul S. Anderson [États-Unis] | Dopamine receptors labelled by PHNO |
| 004D21 | Philip Seeman [Canada] ; Dimitri Grigoriadis [Canada] | Dopamine receptors in brain and periphery |
| 004D52 | Philip Seeman [Canada] ; Natalie H. Bzowej [Canada] ; H. Guan [République populaire de Chine] ; Catherine Bergeron [Canada] ; Lawrence E. Becker [Canada] ; Gavin P. Reynolds ; E. D. Bird [États-Unis] ; Peter Riederer [Autriche] ; Kurt Jellinger [Autriche] ; Shuzo Watanabe ; Wallace W. Tourtellotte [États-Unis] | Human brain dopamine receptors in children and aging adults |
| 004D62 | Philip Seeman [Canada] | Dopamine receptors and the dopamine hypothesis of schizophrenia |
| 004D63 | Philip Seeman [Canada] ; Mark Guttman [Canada] | Dopamine receptor elevation in denervated tissues |
| 005124 | Philip Seeman [Canada] | Nomenclature of central and peripheral dopaminergic sites and receptors |
| 005186 | Tyrone Lee [Canada] ; Philip Seeman [Canada] ; Oleh Hornykiewicz [Canada] ; Juan Bilbao [Canada] ; John Deck [Canada] ; Wallace W. Tourtellotte [États-Unis] | Parkinson's disease: low density and presynaptic location of D3 dopamine receptors |
| This area was generated with Dilib version V0.6.29. |  |